(Q34915414)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933971%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Cometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933971%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933971%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

H Li

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933971%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

language of work or name

English

0 references

publication date

9 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933971%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933971%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933971%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933971%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

574-581

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933971%20AND%20SRC:MED&resulttype=core&format=json

Metagenomic analysis of the human distal gut microbiome

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

The gut flora as a forgotten organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Diversity of the human gastrointestinal tract microbiota revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Diversity of the human intestinal microbial flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Host-gut microbiota metabolic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Colonization-induced host-gut microbial metabolic interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Systemic gut microbial modulation of bile acid metabolism in host tissue compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Functional interactions between the gut microbiota and host metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

TGR5-mediated bile acid sensing controls glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Development of the human infant intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Vaginal microbiome of reproductive-age women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Antibiotic administration alters the community structure of the gastrointestinal micobiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Gut microbiota in 2012: Toward understanding and manipulating the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Antibiotics in early life alter the murine colonic microbiome and adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

The role of the gut microbiota in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

The lactic acid bacteria: a literature survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Bacterial replacement therapy: adapting ‘germ warfare’ to infection prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Gut microorganisms, mammalian metabolism and personalized health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Current concepts of mechanisms in drug-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Drug-induced liver disorders: implications for drug development and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Drug-induced hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Impact of gut microbiota on intestinal and hepatic levels of phase 2 xenobiotic-metabolizing enzymes in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Mutagen excretion and cytochrome P-450-dependent activity in germfree and conventional rats fed a diet containing fried meat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Formation of Phenolic and Indolic Compounds by Anaerobic Bacteria in the Human Large Intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Human sulfotransferases and their role in chemical metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Urinary tract abnormalities in Chinese rural children who consumed melamine-contaminated dairy products: a population-based screening and follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Melamine-induced renal toxicity is mediated by the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Purification and characterization of uridine and thymidine phosphorylase from Lactobacillus casei

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Phosphorolysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and other 5-substituted-2'-deoxyuridines by purified human thymidine phosphorylase and intact blood platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Gut microbiota: metagenomics to study complex ecology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Studying the human gut microbiota in the trans-omics era--focus on metagenomics and metabonomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Immunity, inflammation, and allergy in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Pharmacogenetics, pharmacogenomics, and individualized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

The gastrointestinal microbiota as a site for the biotransformation of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

The role of gut microbiota in drug response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Pharmacogenomics and "individualized drug therapy": high expectations and disappointing achievements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Pharmaco-metabonomic phenotyping and personalized drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Enteric microbiome metabolites correlate with response to simvastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

Gut microbiota: a potential new territory for drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

The human microbiome: at the interface of health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

7 January 2021

Role of Kupffer cells, endotoxin and free radicals in hepatotoxicity due to prolonged alcohol consumption: studies in female and male rats

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

7 January 2021

Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

7 January 2021

Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

7 January 2021

Inactivation of Digoxin by the Gut Flora: Reversal by Antibiotic Therapy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

7 January 2021

Digoxin-inactivating bacteria: identification in human gut flora

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

7 January 2021

Deaths bring clinical trials under scrutiny in Japan.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

7 January 2021

Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.157

7 January 2021